Cole Laboratory

Pediatric Cancer Research Lab

Research and Current Funding

Brain dysfunction is one example of chemotherapy-related toxicity that can affect children with cancer during, and long after, curative treatment. Survivors of childhood cancer are more likely than people who were never treated for cancer to exhibit decreased attention span, poor working memory, and problems with executive functions like cognitive flexibility and task shifting, impulse control, planning, focusing attention, and remembering complex instructions.

$2Million Grant from Merck Foundation September 2022

$2Million Grant from Merck Foundation to Advance Equitable Cancer Care in New Jersey

RWJBarnabas Health, in partnership with Rutgers Cancer Institute of New Jersey, announced it is a grantee supported through the Alliance for Equity in Cancer Care, funded by the Merck Foundation and designed to make cancer care more equitable in the United States by helping patients living in underserved communities receive timely access to high-quality, culturally responsive care.

Welcoming Dr. Matasar

Welcoming the New Chief of Blood Disorders

Matthew Matasar, MD, MS, has been named Chief of Blood Disorders at New Jersey’s leading cancer center and the only one in the state designated as a Comprehensive Cancer Center by the National Cancer Institute. In this role, he will oversee the Sections of Hematologic Malignancies; Transplant and Cell Therapy; and Benign Hematology. Read more